Estimated reading time: 3 minute(s)
The worldwide race to discover Covid-19 vaccine is on and seems to be gaining momentum.
The collaboration between Wits University and Oxford University to do the trial has been given a greenlight.
This announcement was made public on Tuesday in a press briefing held via Zoom.
The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19.
Two thousand participants between the ages of 18-65 are taking part with fifty participants being HIV positive.
The trial is being funded by the South African Medical Research Council and the Bill and Melinda Gates Foundation.
Professor of Vaccinology at Wits University and director of SAMRC’s Vaccines and Infectious Diseases Analytics (VIDA) Research Unit, Shabir Madhi, is set to lead the South African Ox1Cov-19 Vaccine VIDA-Trial.
Madhi said this is a landmark moment for South Africa and Africa at this stage of the COVID-19 pandemic.
Watch the announcement below.